Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial (Q49044088)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 September 2016

Language	Label	Description	Also known as
English	Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial	scientific article published on 16 September 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

0 references

hospitalization

1 reference

based on heuristic

inferred from title

acute decompensated heart failure

1 reference

based on heuristic

inferred from title

Paul W. Armstrong

8

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

object named as

John J McMurray

7

0 references

5

object named as

Javed Butler

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

Christopher M O'Connor

10

object named as

Christopher M O'Connor

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

6

object named as

Marco Metra

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

11

object named as

Karl Swedberg

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

Randall C Starling

9

object named as

Randall C Starling

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Robert J. Mentz

3

object named as

Robert J Mentz

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Adrian F. Hernandez

4

object named as

Adrian F Hernandez

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

W.H. Wilson Tang

12

object named as

W H Wilson Tang

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Justin L Grodin

2

object named as

Justin L Grodin

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

author name string

Takeshi Kitai

1

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

publication date

16 September 2016

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

19

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

2

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

241-249

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Resting heart rate in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF).

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Effect of nesiritide in patients with acute decompensated heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Neurohormonal activation in acute heart failure: results from VERITAS.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Sympathetic nervous system activation in human heart failure: clinical implications of an updated model

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Heart failure as an autonomic nervous system dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Resting heart rate and risk of incident heart failure: three prospective cohort studies and a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Discharge heart rate and β-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

21 January 2018

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

7 January 2021

based on heuristic

inferred from DOI database lookup

Defective cardiac parasympathetic control in patients with heart disease

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

7 January 2021

based on heuristic

inferred from DOI database lookup

The fear of beta-blocker therapy in heart failure: time to forget

1 reference

https://api.crossref.org/works/10.1002%2FEJHF.629

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJHF.629

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 February 2018

http://europepmc.org/abstract/MED/27634557

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49044088&oldid=2220543222"